127 related articles for article (PubMed ID: 38401463)
1. Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights.
Laabi S; LeMmon C; Vogel C; Chacon M; Jimenez VM
Int Immunopharmacol; 2024 Mar; 130():111753. PubMed ID: 38401463
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice.
Zanikov T; Gerasymchuk M; Ghasemi Gojani E; Robinson GI; Asghari S; Groves A; Haselhorst L; Nandakumar S; Stahl C; Cameron M; Li D; Rodriguez-Juarez R; Snelling A; Hudson D; Fiselier A; Kovalchuk O; Kovalchuk I
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985596
[TBL] [Abstract][Full Text] [Related]
3. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Madsen MK; Fisher PM; Burmester D; Dyssegaard A; Stenbæk DS; Kristiansen S; Johansen SS; Lehel S; Linnet K; Svarer C; Erritzoe D; Ozenne B; Knudsen GM
Neuropsychopharmacology; 2019 Jun; 44(7):1328-1334. PubMed ID: 30685771
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages.
Chen HG; Xie KL; Han HZ; Wang WN; Liu DQ; Wang GL; Yu YH
Int J Surg; 2013; 11(10):1060-6. PubMed ID: 24148794
[TBL] [Abstract][Full Text] [Related]
5. The combination of ciprofloxacin and indomethacin suppresses the level of inflammatory cytokines secreted by macrophages in vitro.
Liu K; Yu J; Xia Y; Zhang LT; Li SY; Yan J
Chin J Traumatol; 2022 Nov; 25(6):379-388. PubMed ID: 35697590
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.
Brown RT; Nicholas CR; Cozzi NV; Gassman MC; Cooper KM; Muller D; Thomas CD; Hetzel SJ; Henriquez KM; Ribaudo AS; Hutson PR
Clin Pharmacokinet; 2017 Dec; 56(12):1543-1554. PubMed ID: 28353056
[TBL] [Abstract][Full Text] [Related]
7. [The anti-inflammatory effects of idazoxan on inflammatory mediator release in endotoxin-challenged mice in vivo and activated macrophages in vitro].
Li X; Zhu J; Ma W; Luo L; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):445-9. PubMed ID: 29920042
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin's main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma.
Kolaczynska KE; Liechti ME; Duthaler U
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122486. PubMed ID: 33485158
[TBL] [Abstract][Full Text] [Related]
9. Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1/2 and JNK pathway.
Rosa SI; Rios-Santos F; Balogun SO; Martins DT
Phytomedicine; 2016 Jan; 23(1):9-17. PubMed ID: 26902402
[TBL] [Abstract][Full Text] [Related]
10. Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin.
Dahmane E; Hutson PR; Gobburu JVS
Clin Pharmacol Drug Dev; 2021 Jan; 10(1):78-85. PubMed ID: 32250059
[TBL] [Abstract][Full Text] [Related]
11. [Role of bone marrow tyrosine kinase on chromosome X in the production of pro-inflammatory cytokines from mouse mononuclear-macrophages RAW264.7 induced by endotoxin/lipopolysaccharide and its mechanism].
Fang X; Hu Y; Wang Y; Liu S; Wang F; Chen XL
Zhonghua Shao Shang Za Zhi; 2017 Apr; 33(4):211-216. PubMed ID: 28427134
[No Abstract] [Full Text] [Related]
12. A technique for the rapid isolation and identification of psilocin from psilocin/psilocybin-containing mushrooms.
Lee RE
J Forensic Sci; 1985 Jul; 30(3):931-41. PubMed ID: 4040953
[TBL] [Abstract][Full Text] [Related]
13. Utility of preclinical models in the study of psilocybin - A comprehensive review.
Pedicini M; Cordner ZA
Neurosci Biobehav Rev; 2023 Mar; 146():105046. PubMed ID: 36646257
[TBL] [Abstract][Full Text] [Related]
14. Effects of compounds from bi-qi capsule on the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Wang QS; Cui YL; Wang YF; Chi W
J Ethnopharmacol; 2011 Jul; 136(3):480-7. PubMed ID: 20558268
[TBL] [Abstract][Full Text] [Related]
15.
Jones NT; Wagner L; Hahn MCP; Scarlett CO; Wenthur CJ
Front Psychiatry; 2023; 14():1303365. PubMed ID: 38264637
[TBL] [Abstract][Full Text] [Related]
16.
Thomann J; Kolaczynska KE; Stoeckmann OV; Rudin D; Vizeli P; Hoener MC; Pryce CR; Vollenweider FX; Liechti ME; Duthaler U
Front Pharmacol; 2024; 15():1391689. PubMed ID: 38741590
[No Abstract] [Full Text] [Related]
17. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin.
Qureshi AA; Tan X; Reis JC; Badr MZ; Papasian CJ; Morrison DC; Qureshi N
Lipids Health Dis; 2011 Dec; 10():239. PubMed ID: 22185406
[TBL] [Abstract][Full Text] [Related]
19. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
Ezeaka UC; Kim HJJ; Laprairie RB
Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
[TBL] [Abstract][Full Text] [Related]
20. Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Gomonit MM; Skillman B; Swortwood MJ
J Forensic Sci; 2024 Mar; 69(2):678-687. PubMed ID: 38140718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
